Tang Kevin
Aurinia Pharmaceuticals Inc. · Chief Executive Officer
Tang Kevin is listed in public filings as director, 10 percent owner, officer: Chief Executive Officer. This Tang Kevin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Aurinia Pharmaceuticals Inc. (AUPH), and Singular Genomics Systems, Inc. (OMIC). Investors use Tang Kevin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $199M13M shares | BuyJun 2, 2026 | $3.1M206k shares | $15.28 | -- | |
| $150k10k shares | OtherJun 2, 2026 | $150.0K10k shares | $15.00 | -- |